Tag: longevity
-
Kurzweil predicted three bridges to radical life extension by the 2030s. The first one got demoted, the second arrived in eighteen patients’ eyes, and the third does not exist.
-
Kurzweil predicted animal aging research would translate to human therapies by the 2020s. The worms did exactly what he said. The translation hit the FDA wall.
-
Kurzweil predicted FIRKO-style metabolic engineering would slim humans and reverse aging in the 2020s. The mice held up. The mechanism didn’t.
-
Awareness has saturated; the bridges to radical life extension haven’t. A scorecard on Kurzweil’s longevity predictions twenty years on.
-
The 2020s were supposed to inflect life expectancy upward. They didn’t. But the molecular machinery Kurzweil predicted just entered human trials.
-
Twelve Kurzweil longevity predictions from 2005, scored against a 2025 mouse rejuvenation trial, a 2026 first-in-human reprogramming IND, 25 senolytic clinical trials, and one bankruptcy.
-
Kurzweil in 2005 picked torcetrapib and Apo-A-I Milano as his evidence that atherosclerosis reversal was imminent. Both failed. The drugs that actually regressed plaque came from mechanisms his book did not name.
-
Seven 2005 predictions about replacement organs, therapeutic cloning, and bloodstream nanobots — graded against 2026 reality.